表紙
市場調查報告書

臨床性風險分類解決方案的全球市場 至2024年的預測:計分卡 & 視覺化工具,儀表板分析解決方案,風險匯報解決方案

Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 909746
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
臨床性風險分類解決方案的全球市場 至2024年的預測:計分卡 & 視覺化工具,儀表板分析解決方案,風險匯報解決方案 Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024
出版日期: 2019年08月23日內容資訊: 英文 130 Pages
簡介

臨床性風險分類解決方案的市場規模,預計將從2019年的4億2,700萬美元,到2024年達到8億2,900萬美元的規模。風險管理及巨量資料解決方案的重視,促進該市場。可是,支援基礎設施的不足,可能抑制該技術在預測期間內的市場成長。

本報告提供全球臨床性風險分類解決方案市場的現況與預測的調查分析,市場概要,各種市場影響因素分析,各市場區隔、各地區的市場分析與預測,競爭環境分析,主要經營者的簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 臨床性風險分類解決方案:市場概要
  • 臨床性風險分類解決方案市場:各地區的成長機會
  • 地區混合:臨床性風險分類解決方案市場
  • 臨床性風險分類解決方案市場:已發展的市場 vs. 新興市場

第5章 市場概要

  • 簡介
  • 市場動態
    • 市場推動因素
    • 阻礙市場的要素
    • 市場機會
    • 課題
    • 緊急的問題

第6章 臨床性風險分類解決方案市場:

  • 簡介
  • 計分卡 & 視覺化工具
  • 儀表板分析解決方案
  • 風險匯報解決方案

第7章 臨床性風險分類解決方案市場:各部署模型

  • 簡介
  • 私有雲端
  • 公共雲端
  • 混合雲端

第8章 臨床性風險分類解決方案市場:各終端用戶

  • 簡介
  • 醫院
  • 保險者
  • 門診病人診療中心
  • 長期療養設施
  • 其他終端用戶

第9章 臨床性風險分類解決方案市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭環境

  • 簡介
  • 競爭領導製圖
  • 企業分析:各產品、終端用戶
  • 競爭情形、趨勢

第11章 企業簡介

  • 3M COMPANY
  • OPTUM INC. (SUBSIDIARY OF UNITEDHEALTH GROUP INC.)
  • NUANCE COMMUNICATIONS
  • CONDUENT INCORPORATED
  • CERNER CORPORATION
  • HBI SOLUTIONS, INC.
  • 4S INFORMATION SYSTEMS LTD.
  • JOHNS HOPKINS UNIVERSITY
  • LIGHTBEAM HEALTH SOLUTIONS, LLC
  • DYNAMIC HEALTHCARE SYSTEMS, INC.
  • PERAHEALTH, INC.
  • HEALTH CATALYST INC.
  • EVOLENT HEALTH

第12章 附錄

目錄
Product Code: HIT 7312

"Increasing focus on risk management solutions is expected to drive the growth of the clinical risk grouping solutions market"

The clinical risk grouping solutions market is projected to reach USD 829 million by 2024 from USD 427 million in 2019, at a CAGR of 14.2%. Focus on risk management and big data solutions are driving the market for clinical risk grouping solutions. However, a lack of infrastructure for supporting this technology is expected to restrain the growth of the market to a certain extent during the forecast period.

Dashboard analytics segment to show the fastest growth during the forecast period

Based on product, the clinical risk grouping solutions market is segmented into three major categories, viz., scorecard & visualization tools, dashboard analytics, and risk reporting. The dashboard analytics segment is expected to witness one of the highest CAGR within the clinical risk grouping solutions market. High adoption of dashboard analytics by healthcare providers, the increasing adoption of risk management solutions in the healthcare industry, growing requirements for accuracy & quality of patient care, and the rising use of big data solutions in healthcare are driving the growth of the segment.

Private cloud to hold the largest share of the clinical risk grouping solutions market during the forecast period

Based on the deployment model, the clinical risk grouping solutions market is segmented into private cloud, public cloud, and hybrid cloud. In 2018, the private cloud segment accounted for the dominant share of the clinical risk grouping solutions market. The large share of this segment is attributed to the fact that private cloud deployment offers the best security for sensitive data. Additionally, a private cloud offers on-demand infrastructure with dedicated resources that can be shared across domains, applications, and units within the same organization.

North America accounted for the largest share of the market in 2018, whereas the Asia Pacific is expected to be the fastest-growing market

The study discusses the clinical risk grouping solutions market trends for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the global clinical risk grouping solutions market. The large share of North America can be attributed to the support for adopting HCIT by providers and payers, increasing focus on population health services, and greater availability of clinical risk grouping solutions

However, Asia Pacific is expected to be the fastest-growing market with the highest CAGR during the forecast period. Factors such as the presence of a larger patient population demanding better healthcare at lower costs, economic growth, rising geriatric population, emergence of big data in healthcare, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the clinical risk grouping solutions market in the Asia Pacific.

The breakup of primary participants is as mentioned below:

  • By Company Type: Tier 1 (50%), Tier 2 (10%), and Tier 3 (40%)
  • By Designation: C-level (10%), Director-level (30%), and Others (60%)
  • By Region: North America (40%), Europe (30%), Asia Pacific (10%), Latin America (10%), and the Middle East and Africa (10%)

The prominent players in the global clinical risk grouping solutions market are: 3M Corporation (US), Optum Inc. (US), Cerner Corporation (US), Conduent Inc. (US), Nuance Communications (US), Health Catalyst (US), HBI Solutions (US), Johns Hopkins University (US), Lightbeam Health Solutions (US), Dynamic Healthcare Systems (US), 4S Information Systems (US), Evolent Health (US), and PeraHealth (US).

Research Coverage:

The report analyzes the clinical risk grouping solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product, deployment model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the global clinical risk grouping solutions market. The report analyzes this market by product, deployment model, end-user, and region
  • Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global clinical risk grouping solutions market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, deployment model, end-user, and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global clinical risk grouping solutions market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global clinical risk grouping solutions market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION APPROACH
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL RISK GROUPING SOLUTIONS: MARKET OVERVIEW
  • 4.2 CLINICAL RISK GROUPING SOLUTIONS MARKET: GEOGRAPHIC

GROWTH OPPORTUNITIES 30

  • 4.3 REGIONAL MIX: CLINICAL RISK GROUPING SOLUTIONS MARKET (2019-2024)
  • 4.4 CLINICAL RISK GROUPING SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing focus on risk management
      • 5.2.1.2 Rising usage of big data solutions
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of infrastructure
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing physician burnout due to documentation needs
      • 5.2.3.2 Increasing focus on AI and machine learning
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Scarcity of skilled healthcare IT professionals
      • 5.2.4.2 Patient data privacy concerns
    • 5.2.5 BURNING ISSUE
      • 5.2.5.1 Implementation of solutions reduces administrative expenses but increases the burden on patients

6 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 SCORECARDS & VISUALIZATION TOOLS
    • 6.2.1 NEED TO INCREASE PATIENT ACCURACY AND FORECAST RISKS ARE DRIVING DEMAND FOR SCORECARDS & VISUALIZATION TOOLS
  • 6.3 DASHBOARD ANALYTICS SOLUTIONS
    • 6.3.1 DASHBOARD ANALYTICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 6.4 RISK REPORTING SOLUTIONS
    • 6.4.1 INCREASING ADOPTION OF RISK MANAGEMENT SOLUTIONS BY HEALTHCARE PROVIDERS TO FUEL MARKET GROWTH

7 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL

  • 7.1 INTRODUCTION
  • 7.2 PRIVATE CLOUD
    • 7.2.1 HIGH DATA SECURITY OF PRIVATE CLOUD MODELS IS DRIVING

MARKET GROWTH 46

  • 7.3 PUBLIC CLOUD
    • 7.3.1 PRICE-EFFECTIVENESS OF PUBLIC OVER PRIVATE CLOUDS HAS

DRIVEN END-USER PREFERENCE 47

  • 7.4 HYBRID CLOUD
    • 7.4.1 HYBRID CLOUD ARCHITECTURE PROVIDE FLEXIBILITY AND THE ABILITY

TO AVOID VENDOR LOCK-IN 48

8 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 HOSPITALS ARE THE LARGEST END USERS OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET
  • 8.3 PAYERS
    • 8.3.1 PAYERS USE CLINICAL RISK GROUPING SOLUTIONS FOR RISK MANAGEMENT, IDENTIFYING CLAIMS TRENDS, AND MAXIMIZING PAYMENT ACCURACY
  • 8.4 AMBULATORY CARE CENTERS
    • 8.4.1 IMPLEMENTATION OF MANDATES TO COMPLY WITH QUALITY MEASURES TO SUPPORT THE ADOPTION OF CLINICAL RISK GROUPING SOLUTIONS IN AMBULATORY CARE CENTERS
  • 8.5 LONG-TERM CARE CENTERS
    • 8.5.1 GROWING NUMBER OF LONG-TERM CARE CENTERS TO DRIVE

MARKET GROWTH 55

  • 8.6 OTHER END USERS

9 CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US dominates the North American clinical risk grouping

solutions market 64

    • 9.2.2 CANADA
      • 9.2.2.1 Growing need for cost containment in healthcare will propel market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Infrastructural development and focus on risk management have driven market growth in Germany
    • 9.3.2 UK
      • 9.3.2.1 Favorable regulatory outlook has pushed the adoption of HCIT solutions in the UK
    • 9.3.3 FRANCE
      • 9.3.3.1 Initiatives taken by the French government to promote the use of healthcare IT solutions will drive market growth
    • 9.3.4 REST OF EUROPE (ROE)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA IS EXPECTED TO WITNESS HIGH GROWTH IN POPULATION AND DEMAND FOR HEALTHCARE SERVICES
  • 9.5 LATIN AMERICA
    • 9.5.1 COUNTRIES SUCH AS BRAZIL AND MEXICO ARE EXPLORING NEW METHODS TO MANAGE CLINICAL INFORMATION
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 MIDDLE EASTERN COUNTRIES ARE INVESTING SIGNIFICANTLY IN HCIT INFRASTRUCTURAL DEVELOPMENT

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 COMPETITIVE LEADERSHIP MAPPING
    • 10.2.1 VISIONARY LEADERS
    • 10.2.2 INNOVATORS
    • 10.2.3 DYNAMIC DIFFERENTIATORS
    • 10.2.4 EMERGING COMPANIES
  • 10.3 COMPANY ANALYSIS, BY PRODUCT AND END USER
  • 10.4 COMPETITIVE SITUATIONS AND TRENDS

11 COMPANY PROFILE

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1 3M COMPANY
  • 11.2 OPTUM INC. (SUBSIDIARY OF UNITEDHEALTH GROUP INC.)
  • 11.3 NUANCE COMMUNICATIONS
  • 11.4 CONDUENT INCORPORATED
  • 11.5 CERNER CORPORATION
  • 11.6 HBI SOLUTIONS, INC.
  • 11.7 4S INFORMATION SYSTEMS LTD.
  • 11.8 JOHNS HOPKINS UNIVERSITY
  • 11.9 LIGHTBEAM HEALTH SOLUTIONS, LLC
  • 11.10 DYNAMIC HEALTHCARE SYSTEMS, INC.
  • 11.11 PERAHEALTH, INC.
  • 11.12 HEALTH CATALYST INC.
  • 11.13 EVOLENT HEALTH

Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 MARKET SIZING & VALIDATION APPROACH
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 3: SCORECARDS AND VISUALIZATION TOOLS: KEY BRANDS
  • TABLE 4: SCORECARDS & VISUALIZATION TOOLS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: DASHBOARD ANALYTICS: KEY BRANDS
  • TABLE 6: DASHBOARD ANALYTICS SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: RISK REPORTING: KEY BRANDS
  • TABLE 8: RISK REPORTING SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 10: PRIVATE CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 11: PUBLIC CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 12: HYBRID CLOUD-DEPLOYED CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 14: CLINICAL RISK GROUPING SOLUTIONS FOR HOSPITALS
  • TABLE 15: CLINICAL RISK GROUPING SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 16: CLINICAL RISK GROUPING SOLUTIONS FOR PAYERS
  • TABLE 17: CLINICAL RISK GROUPING SOLUTIONS MARKET FOR PAYERS, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 18: CLINICAL RISK GROUPING SOLUTIONS FOR AMBULATORY CARE CENTERS
  • TABLE 19: CLINICAL RISK GROUPING SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 20: CLINICAL RISK GROUPING SOLUTIONS FOR LONG-TERM CARE CENTERS
  • TABLE 21: CLINICAL RISK GROUPING SOLUTIONS MARKET FOR LONG-TERM CARE CENTERS, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CLINICAL RISK GROUPING SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2017-2024 (USD MILLION)
  • TABLE 23: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 28: US: KEY MACROINDICATORS
  • TABLE 29: US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 30: US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 31: US: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 32: CANADA: KEY MACROINDICATORS
  • TABLE 33: CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 34: CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 35: CANADA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 36: EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 38: EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 39: EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 40: GERMANY: KEY MACROINDICATORS
  • TABLE 41: GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 42: GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 43: GERMANY: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 44: UK: KEY MACROINDICATORS
  • TABLE 45: UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 46: UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 47: UK: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 48: FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 49: FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 50: FRANCE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 51: ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 52: ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 53: ROE: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 54: ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 57: LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 58: LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 59: LATIN AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 60: MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 61: MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2017-2024 (USD MILLION)
  • TABLE 62: MIDDLE EAST AND AFRICA: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 63: PRODUCT LAUNCHES AND ENHANCEMENTS (2017-2019)
  • TABLE 64: ACQUISITIONS, JOINT VENTURES, AND MERGERS (2018-2019)
  • TABLE 65: COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2018-2019)
  • TABLE 66: EXPANSIONS (2017)

LIST OF FIGURES

  • FIGURE 1: CLINICAL RISK GROUPING SOLUTIONS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT MODEL, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET
  • FIGURE 11: INCREASING FOCUS ON RISK MANAGEMENT IS THE MAJOR FACTOR DRIVING THE ADOPTION OF CLINICAL RISK GROUPING SOLUTIONS
  • FIGURE 12: ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA WILL CONTINUE TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET IN 2024
  • FIGURE 14: ASIA PACIFIC MARKET TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
  • FIGURE 15: CLINICAL RISK GROUPING SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES
  • FIGURE 16: HEALTHCARE DATA BREACHES IN THE US (2016-2019)
  • FIGURE 17: SCORECARD AND VISUALIZATION TOOLS SEGMENT TO DOMINATE THE CLINICAL RISK GROUPING SOLUTIONS MARKET IN 2019
  • FIGURE 18: PRIVATE CLOUD TO HOLD THE LARGEST SHARE OF THE CLINICAL RISK GROUPING SOLUTIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2019 VS. 2024
  • FIGURE 20: CLINICAL RISK GROUPING SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 21: NORTH AMERICA: CLINICAL RISK GROUPING SOLUTIONS MARKET SNAPSHOT
  • FIGURE 22: EUROPE: CLINICAL RISK GROUPING SOLUTIONS MARKET SNAPSHOT
  • FIGURE 23: KEY DEVELOPMENTS IN THE CLINICAL RISK GROUPING SOLUTIONS MARKET BETWEEN 2016 AND 2019
  • FIGURE 24: CLINICAL RISK GROUPING SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2018)
  • FIGURE 25: 3M AND OPTUM ARE THE LEADING PLAYERS IN THE CLINICAL RISK GROUPING SOLUTIONS MARKET
  • FIGURE 26: 3M COMPANY: COMPANY SNAPSHOT
  • FIGURE 27: OPTUM INC.: COMPANY SNAPSHOT
  • FIGURE 28: NUANCE COMMUNICATIONS: COMPANY SNAPSHOT
  • FIGURE 29: CONDUENT INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 30: CERNER: COMPANY SNAPSHOT
  • FIGURE 31: EVOLENT HEALTH: COMPANY SNAPSHOT
Back to Top